Hutchin Hill Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-22,282	Closed	-$1.47M	–	944
2017 Q1	$1.47M	Buy	+22,282	New	+$1.47M	0.04%	375